EA
RETA
Emerald Advisers’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-317,096
| Closed | -$32.3M | – | 247 |
|
|
2023
Q2 | $32.3M | Buy |
317,096
+2,475
| +0.8% | +$252K | 1.41% | 11 |
|
|
2023
Q1 | $28.6M | Sell |
314,621
-365,151
| -54% | -$33.2M | 1.37% | 13 |
|
|
2022
Q4 | $25.8M | Buy |
679,772
+141,520
| +26% | +$5.38M | 1.25% | 27 |
|
|
2022
Q3 | $13.5M | Buy |
538,252
+252,071
| +88% | +$6.33M | 0.7% | 65 |
|
|
2022
Q2 | $8.7M | Buy |
286,181
+15,335
| +6% | +$466K | 0.45% | 85 |
|
|
2022
Q1 | $8.87M | Buy |
270,846
+91,974
| +51% | +$3.01M | 0.34% | 99 |
|
|
2021
Q4 | $4.72M | Sell |
178,872
-97,283
| -35% | -$2.57M | 0.17% | 113 |
|
|
2021
Q3 | $27.8M | Buy |
276,155
+29,712
| +12% | +$2.99M | 1.01% | 35 |
|
|
2021
Q2 | $34.9M | Sell |
246,443
-15,024
| -6% | -$2.13M | 1.27% | 21 |
|
|
2021
Q1 | $26.1M | Buy |
+261,467
| New | +$26.1M | 0.94% | 31 |
|
|
2020
Q3 | – | Sell |
-63,472
| Closed | -$9.9M | – | 365 |
|
|
2020
Q2 | $9.9M | Sell |
63,472
-51,064
| -45% | -$7.97M | 0.43% | 87 |
|
|
2020
Q1 | $16.5M | Buy |
114,536
+12,427
| +12% | +$1.79M | 0.96% | 35 |
|
|
2019
Q4 | $20.9M | Sell |
102,109
-180,709
| -64% | -$36.9M | 0.88% | 41 |
|
|
2019
Q3 | $22.7M | Sell |
282,818
-104,551
| -27% | -$8.39M | 1.06% | 32 |
|
|
2019
Q2 | $36.5M | Sell |
387,369
-4,720
| -1% | -$445K | 1.47% | 18 |
|
|
2019
Q1 | $33.5M | Sell |
392,089
-78,342
| -17% | -$6.7M | 1.36% | 20 |
|
|
2018
Q4 | $26.4M | Sell |
470,431
-2,844
| -0.6% | -$160K | 1.3% | 20 |
|
|
2018
Q3 | $38.7M | Sell |
473,275
-72,245
| -13% | -$5.91M | 1.42% | 11 |
|
|
2018
Q2 | $19.1M | Buy |
545,520
+51,767
| +10% | +$1.81M | 0.72% | 61 |
|
|
2018
Q1 | $10.1M | Sell |
493,753
-67,983
| -12% | -$1.39M | 0.41% | 102 |
|
|
2017
Q4 | $15.9M | Sell |
561,736
-7,680
| -1% | -$217K | 0.61% | 65 |
|
|
2017
Q3 | $17.7M | Buy |
569,416
+162,990
| +40% | +$5.07M | 0.72% | 59 |
|
|
2017
Q2 | $12.9M | Buy |
406,426
+36,227
| +10% | +$1.15M | 0.54% | 78 |
|
|
2017
Q1 | $8.39M | Buy |
370,199
+43,052
| +13% | +$975K | 0.34% | 103 |
|
|
2016
Q4 | $7.14M | Buy |
327,147
+86,269
| +36% | +$1.88M | 0.3% | 104 |
|
|
2016
Q3 | $6.35M | Buy |
240,878
+73,268
| +44% | +$1.93M | 0.28% | 122 |
|
|
2016
Q2 | $3.31M | Buy |
+167,610
| New | +$3.31M | 0.16% | 160 |
|